Octreotide (Short-acting)



ATC CODE

  • H01CB02

INDICATION

  • Persistent neonatal hyperinsulinism and hypoglycaemia.

NEMLC RECOMMENDATION

  • Approved
    The condition is rare; usage is for short term; alternative agents are limited and the consequences of not having treatment available are serious.